BE849897A - Vaccins vivants contre la varicelle et le zona - Google Patents

Vaccins vivants contre la varicelle et le zona

Info

Publication number
BE849897A
BE849897A BE173669A BE173669A BE849897A BE 849897 A BE849897 A BE 849897A BE 173669 A BE173669 A BE 173669A BE 173669 A BE173669 A BE 173669A BE 849897 A BE849897 A BE 849897A
Authority
BE
Belgium
Prior art keywords
zona
vaccines
live varicella
varicella
live
Prior art date
Application number
BE173669A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE849897A publication Critical patent/BE849897A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16763—Methods of inactivation or attenuation by chemical treatment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/821—Drug, bio-affecting and body treating compositions involving temperature-sensitive mutant virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BE173669A 1975-12-29 1976-12-28 Vaccins vivants contre la varicelle et le zona BE849897A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/644,787 US4008317A (en) 1975-12-29 1975-12-29 Varicella-zoster virus vaccine and preparation thereof

Publications (1)

Publication Number Publication Date
BE849897A true BE849897A (fr) 1977-06-28

Family

ID=24586321

Family Applications (1)

Application Number Title Priority Date Filing Date
BE173669A BE849897A (fr) 1975-12-29 1976-12-28 Vaccins vivants contre la varicelle et le zona

Country Status (6)

Country Link
US (1) US4008317A (OSRAM)
JP (1) JPS5282721A (OSRAM)
BE (1) BE849897A (OSRAM)
DE (1) DE2655691C2 (OSRAM)
FR (1) FR2336944A1 (OSRAM)
GB (1) GB1565830A (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043847A4 (en) * 1980-01-25 1982-07-06 Wistar Inst HIGHLY ATTENUED CHICKENPOX VIRUS VACCINE AND PRODUCTION THEREOF.
US4315914A (en) * 1980-04-04 1982-02-16 Seiji Arakawa Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof
US4714678A (en) * 1982-10-13 1987-12-22 Smithkline-Rit Temperature sensitive strain of bovine viral diarrhoea virus
IT1213254B (it) * 1984-12-06 1989-12-14 Boehringer Biochemia Srl Metodo diagnostico per la valutazione di parametri clinici mediante prelievo diretto dimateriali biologici e dispositivoper la sua attuazione.
ES2150906T3 (es) 1990-10-04 2000-12-16 Res Corp Technologies Inc Antigeno del virus varicella-zoster.
US5824319A (en) * 1990-10-04 1998-10-20 Research Corporation Technologies, Inc. Varicella-zoster virus antigen
JP4562812B2 (ja) * 1992-07-17 2010-10-13 メルク・シャープ・エンド・ドーム・コーポレイション 帯状疱疹の予防または水痘関連ヘルペス後神経痛の緩和方法
US5879675A (en) * 1994-03-15 1999-03-09 Medical College Of Pennsylvania And Hahnemann University Compositions and methods for vaccines comprising α-galactosyl epitopes
US7666082B2 (en) * 2004-05-07 2010-02-23 Gamelogic Inc. Method and apparatus for conducting a game of chance
US10350289B2 (en) 2013-09-05 2019-07-16 Merck Sharp & Dohme Corp. Methods of immunization with varicella zoster virus antigen

Also Published As

Publication number Publication date
US4008317A (en) 1977-02-15
JPS5282721A (en) 1977-07-11
GB1565830A (en) 1980-04-23
FR2336944B1 (OSRAM) 1980-07-18
FR2336944A1 (fr) 1977-07-29
DE2655691C2 (de) 1985-08-14
JPS624370B2 (OSRAM) 1987-01-30
DE2655691A1 (de) 1977-07-14

Similar Documents

Publication Publication Date Title
BE878430A (fr) Vaccins contre la pasteurellose
DK293575A (da) Triazolyl-alkanoner og -alkanoler samt fremgangsmade til deres fremstilling og deres anvendelse
DK47476A (da) Benzoylureido-diphenylethere samt fremgangsmade til deres fremstilling og anvendelse
BE786240Q (fr) Vaccin contre l'hepatite virale et sa preparation
DK455880A (da) Stabiliseret vaccine og vaccinestabilisator
FR2316201A1 (fr) Similigranite et sa preparation
BE805570A (fr) Vaccins et leur preparation
DK47376A (da) Benzoylureido-nitro-diphenylethere samt fremgangsmade til deres fremstilling og anvendelse
DK385075A (da) 3-phenyl-5-substituerede 4(1h)-pyridoner(thioner) samt deres fremstilling og anvendelse
BE851880A (fr) Vaccins vivants ameliores contre la pseudopeste aviaire
DK56876A (da) Prostaglandinanaloge samt deres fremstilling og anvendelse
DK211775A (da) Substituerede phenylguanidiner samt deres fremstilling og anvendelse
FR2315947A1 (fr) Vaccin contre l'hepatite b
BE849897A (fr) Vaccins vivants contre la varicelle et le zona
DK287476A (da) Pyrrolidoner samt deres fremstilling og anvendelse
NL7804660A (nl) Verbeterde vaccins.
DK353575A (da) 1-thiadiazolylimidazolidinoner samt deres fremstilling og anvendelse
BE832967A (fr) Vaccins contre les enterites
IL51864A (en) Rabies vaccine and its preparation
BE808708A (fr) Vaccins vivants contre la rhinotracheite infectieuse bovine et leur preparation
CA943501A (en) Pole holding and setting device
BE824372A (fr) Vaccins antigrippaux et procede de leur preparation
DK554776A (da) Prostaglandinanaloge pyrrolidoner samt deres fremstilling og anvendelse
GB1543962A (en) Acellular vaccines
DK426376A (da) 4-hydroxymethyl-2-pyrrolidinoner samt deres fremstilling og anvendelse

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SMITH KLINE RIT

Effective date: 19881231